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A B S T R A C T
The obesity epidemic has focused attention on obesity’s health consequences beyond cardio-vascular disease and dia-
betes. To evaluate the potential consequences of obesity for Attention Deficit-Hyperactivity Disorder (ADHD), we surveyed
the literature. Current findings link both obesity and ADHD to the dopamine system and implicate dopamine genes in
body weight, eating, and ADHD. Detailed consideration suggests that dopaminergic changes in the prefrontal cortex
among individuals with the ADHD subtype Attention Deficit Disorder (ADD) may increase their risk for obesity. Thus,
individuals and populations with a high prevalence of hyperdopaminergic genes may experience higher rates of obesity
in the presence of abundant food. From an evolutionary perspective, alterations in the dopamine system appear to effect a
wide range of behavioral phenotypes. We suggest that recent evolutionary changes in the dopamine receptor genes se-
lected to increase cognitive and behavioral flexibility may now be associated with attention problems and increased food
consumption in an obesogenic environment.
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Introduction
The obesity epidemic threatens to have far reaching
and important implications for human health and wel-
fare across the globe1. Concerns about the health impact
of the epidemic have focused largely on increased rates of
diabetes and heart disease2,3. As the epidemic continues,
consideration of its impact is starting to expand to other
outcomes as well, such as the effects of stigmatization
and body dissatisfaction on the psychological well-being
of obese individuals and Alzheimer’s disease4–6.
In addition, to its association with diabetes and cardio-
vascular disease, obesity has been associated with in-
creased risk of psychiatric disorders7,8. Recent studies
have suggested a link between childhood obesity and at-
tention-deficit hyperactivity disorder (ADHD)9–11. In ad-
dition childhood symptoms of ADHD, attention-deficit
subtype (referred to in this paper as Attention Deficient
Disorder or ADD) have been related to subsequent obe-
sity in adults12,13. Together these findings suggest a pos-
sible syndrome linking obesity with ADHD. Thus it is im-
portant to explore the implications of obesity for ADHD
in greater detail.
In this paper we review the literature suggesting that
ADHD, and obesity are related through alterations in the
dopaminergic system. Briefly put, we suggest that indi-
viduals with ADD, in particular, experience »reward defi-
ciency syndrome«as a result of low tonic dopamine levels
in the prefrontal cortex14. Thus they may eat as a form of
self-medication in order to increase their dopamine le-
vels15. Decreased sensitivity to reward would also be as-
sociated with over-eating, leading to an increased risk of
obesity. Thus chronically low levels of dopamine in the
pre-frontal cortex may first be evident as ADD and only
subsequently lead to obesity.
From an evolutionary perspective, we argue that while
ADHD is unlikely to be selected for ADD may be benefi-
cial in some contexts16. Alterations in prefrontal working
memory may increase the impact of dopaminergic stria-
tal activity leading to increased saliency of novelty and
the increased acquisition of information in an unpredict-
able environment17. In addition, increased dopaminergic
striatal activity may lead to an increased importance of
food and sex as rewards18–20. This could promote repro-
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duction under subsistence conditions. The relative bene-
fits of these traits may vary across populations leading to
balanced selection for allelic variants of genes, such as
the 7R allele of the DRD4 dopamine receptor associated
with hypodopominergic function21.
We divide our argument into two parts. In the first
part we provide evidence relating ADHD, obesity and do-
pamine in industrialized societies. Under these condi-
tions, not only has ADHD been associated with obesity,
but obesity has been related to variation in various genes
associated with dopamine metabolism. Finally, dopamine
is directly related to eating, thus providing a behavioral
link between ADHD, dopamine and obesity (See Figure 1
for a diagrammatic illustration).
In the second part of the paper we consider how
ADHD, dopamine, and obesity might be related in subsis-
tence contexts. An anthropological perspective suggests
that individuals with hypodopaminergic reward systems
will exhibit obesity only under conditions of plentiful
food. From an evolutionary perspective the recent emer-
gence and positive selection for the 7R allele of the DRD4
dopamine receptor suggests that there may be benefits to
reduced prefrontal control of striatal impulses associated
with important changes in human social environments
roughly 50,000 years ago21–23, but see 24.
Before we begin, it is important to make a distinction
between ADD and ADHD. Individuals with ADHD are
disorganized, hyperactive, impulsive and socially disrup-
tive25. ADHD is thought to reflect loss of inhibitory con-
trol of motor activity26. In contrast, individuals with
ADD are disorganized, sluggish and bored; ADD is thought
to reflect poor attention associated with deficits in work-
ing memory in the prefrontal cortex27. The most compel-
ling findings link obesity with ADD, not ADHD, suggest-
ing that it is a lack of attention and low energy that may
be associated with obesity, not hyperactivity
ADHD and Obesity
Recent studies of children provide limited evidence of
a connection between ADHD and obesity. A recent Ger-
man study found higher prevalence of overweight among
97 boys (mean age 10 ± 2 years) diagnosed with ADHD
compared to a German reference sample10. Perhaps the
prevalence would be even higher if not for the fact that
many of the drugs used to treat ADHD have side-effects
that include weight loss and vomiting28–30. In addition,
children with ADHD before medication treatment have
slightly higher weight and body-mass index (BMI) than
the general age and gender matched Centers for Disease
Control (CDC) population28–30,31. Finally, a chart review
of 140 children ages 3 to 18 diagnosed with austism and
ADHD, failed to find increased rate of overweight and
obesity compared to U.S. reference values12.
On the other hand, a handful of recent reports indicate
a high prevalence of ADD, the inattentive subtype of
ADHD not associated with hyperactivity, among obese
adults seeking treatment. Among 215 patients receiving
treatment for obesity, 27.4% have symptoms of ADD, in-
cluding 42.6% of those over a BMI of 40, compared to a
prevalence of 4.7% in the general population13. Another
study found that 26.7% of 75 women coming for treatment
reported symptoms of ADHD in childhood and adulthood,
with a high frequency of inattentive symptoms14. While
women seeking treatment for obesity represent a select
sample, the elevated rates of ADD in the two studies cited
above suggest a link between ADD and obesity.
Dopamine, Obesity, and Food
Alterations of the dopaminergic system have also
been related to obesity. Obesity is significantly related to
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Fig. 1. Postulated model of the dopaminergic roots of Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Disorder
(ADD) and Obesity. Functional genetic alterations to the Dopamine Receptors D4 and D2 genes have predominant effects in the pre-
frontal cortex and striatum respectively. The striatum and prefrontal cortex interact via motivation loops with emotional responses in
the striatum being relayed to cognitive processing in the prefrontal cortex. Psychological endophenotypes including altered working
memory, hypo-arousal, easy boredom and altered motivation influence a variety of distal phenotypes. ADD and ADHD are recognized
as having primarily distinct etiologies while both sex drive and obesity are postulated to have dual D2–D4 roots acting through the
striatum and the prefrontal cortex respectively.
the DRD2 TaqI A polymorphism in a sample of Chinese
men in Hong Kong32. The DRD2 TaqI A polymorphism is
associated with altered D2 receptor expression levels in
the striatum33. More recently, in sample of over 1000 in-
dividuals, the low activity versions of monoamine oxidase
A (MAOA) and MAOB genes, which determine the avail-
ability of dopamine (and other catecholamines) were
found to be significantly more prevalent in obese indivi-
duals34. Together the presence of the low activity version
of both genes results in a five-fold increased risk of obe-
sity, strongly implicating the dopamine system in obesity.
The association between dopamine genes and obesity
is presumably mediated by the role of dopamine in eat-
ing35–37. Dopamine increases in response to presentation
of food, even without consumption35,36. Furthermore, the
degree of dopamine increase in response to food presen-
tation is directly related to subjective reports of hunger
and desire for food35.
As might be expected, the role of dopamine in hunger
and food craving is particularly evident in obese individ-
uals. The availability of D2 dopamine receptors in the
striatum are inversely related to BMI in individuals with
a BMI over 4037. The authors suggest that individual
variation in the D2 dopamine receptor may lead to al-
tered tonic levels of striatal dopaminergic activity. Food,
they suggest acts to stimulate dopamine release thus re-
storing dopamine levels. However, a weaker dopamine
response to reward may mean that more food is required
to restore dopamine to an adequate level, thus leading to
overeating and obesity. These findings are based on ex-
tremely obese individuals who may be genetically distin-
ctive38. However, they can probably be extended to ex-
plain the association of ADD and obesity.
ADD, Dopamine, and Eating
Generally speaking, ADHD reflects the effects of do-
paminergic conditions in the striatum and prefrontal
cortex27. ADHD has been related to allelic variations as-
sociated with altered dopamine levels. These include the
DRD4 gene as well as the DRD2 gene39–42. ADHD has
also been linked to higher dopamine transport activi-
ty43,44.
The distinction between prefrontal cortex and striatal
aspects of the dopaminergic system may be crucial for
understanding the relationship between DRD4, ADD
and obesity. Prefrontal dopamine is though to be impor-
tant in cognition while dopamine in the striatum is more
directly related to motivation45. Furthermore dopami-
nergic neurons in the prefrontal cortex exhibit a higher
density of D4 dopamine receptors and lower density of
D2 dopamine receptors than those of the striatum46.
Thus, variation in the D4 dopamine receptor may be
more directly related to ADD47. In contrast, variation in
the D2 dopamine receptor may be more directly related
to impulsivity and/or hyperactivity27.
By definition, deficiencies in working memory lead to
the inability to sustain attention on prolonged or de-
manding tasks. Hence individuals with ADD are prone to
switch to other tasks27. This switch in attention may be
associated with a phasic increase in dopamine reinforc-
ing the reward from novelty. In addition, lower tonic
prefrontal dopamine activity is associated with increased
striatal dopamine activity48. Thus, the dopaminergic re-
ward from activities normally associated with the stria-
tum, namely food and sex, will be relatively stronger,
making them more salient as well
For individuals with ADD food may be particularly sa-
lient. Not only is food readily available in modern devel-
oped countries, but it provides a predictable reward.
Thus ADD may be associated with overeating through 3
potential mechanisms; 1) poor planning associated with
deficient inhibitory control; 2) aversion to delay which
may lead to increased consumption of highly palatable
fast food; 3) self-medication in an attempt to reduce the
lack of satisfaction that comes with low tonic dopamine
levels16. Thus low levels of dopamine in the prefrontal
cortex may be manifested initially as symptoms of ADD,
but also include overeating that eventually leads to obe-
sity in some individuals.
Recent findings among women with seasonal affective
disorder (SAD) provide support for the argument above.
In a sample of women with SAD those with the 7R allele
of the dopamine receptor gene (DRD4) are more likely to
have displayed symptoms of ADD in childhood as well as
higher maximal BMI’s as adults19,20. Women with SAD
are susceptible to binge eating, making overeating the
obvious connection between ADD and elevated BMI.
Anthropological Perspective
The studies cited above suggest a role for the dopa-
minergic system in over eating and obesity in clinical
populations. However, such an argument can easily be
extended to the larger population as well. Palatable food
(i.e. food high in sugar and fat) up-regulates hunger sig-
nals, blunts satiety signals and activates the reward
system49. Thus the abundance of calorically dense food in
our current environment increases the probability that
normal individuals will seek food as a reward and overeat
as well.
The role of low dopamine in linking ADD and obesity
postulated here depends on readily available and abun-
dant food. In subsistence societies, where food resources
and the opportunity for overeating are limited, increased
food craving or hunger associated with a hypodopami-
nergic system would be less likely to lead to hyperphagia
and weight gain. However, as populations modernize and
food becomes more abundant, the role of appetite may
come to play a more prominent role. Thus population dif-
ferences in increasing rates of obesity with moderniza-
tion may reflect variation in allelic frequency of the
DRD4 and DRD2 dopamine genes, among other factors.
The role of dopamine genes in ADHD has been studied in
a variety of cultures, including Taiwan, Chile , Korea
and China41,50–54. However, we are unaware of any stud-
ies of dopamine genes and obesity in non-industrialized
populations.
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Evolutionary Perspective
Current evolutionary arguments suggest that ADHD
is unlikely to be selectively advantageous, because of its
detrimental long term effects on educational attainment
and employment in our society17,55. Similar effects on
learning may have been evident during human evolution
as well. However, to the extent that ADD does not lead to
the same level of socially disruptive behavior it may not
be as detrimental. Thus, the fact the 7R allele of DRD4 is
thought to have been under positive selection since its
emergence approximately 40,000–50,000 ybp suggests
that despite their obvious costs, reduced prefrontal dopa-
mine levels may have been beneficial under some social
conditions22.
We suggest that the 7R allele of DRD4 was under posi-
tive selection to the extent that reduced prefrontal cortical
control of cognition and behavior allowed for increased
flexibility in a dynamic social environment. Reduced
prefrontal control of striatal dopaminergic reward sig-
nals may increase the salience of novelty and disinhibit
behavior associated with rewards such as food and sex.
In children these changes might have lead to more flexi-
ble learning, while among adults they would be associ-
ated with increased attention to the opportunity of food
and sex.
Increased cognitive flexibility is associated with posi-
tive emotions and dopamine is thought to play a role56, 57.
Furthermore, differences in cognitive flexibility have been
associated with the 7R allele of the DRD4 gene58. Thus
while reduced tonic levels of dopamine in the prefrontal
cortex associated with ADD may be associated with a de-
crease in sustained attention, shifting attention to a
novel stimulus may result in a phasic release of dopa-
mine and increase positive feeling59. Among children, the
association of positive feeling together with the stimula-
tion of novelty would promote faster acquisition of new
information, especially under unpredictable conditions.
Faster response times among those with ADHD and 7R
alleles compared to those with ADHD but no 7R alleles
may also aid in rapidly acquiring and implementing new
information60,61.
Reduction of prefrontal dopamine levels may have
been associated with changes in social behavior as well.
The 7R allele has been associated with disorganized in-
fant attachment62,63 though see 64 suggesting a reduced abil-
ity of infants to experience adequate comfort from their
mothers. Furthermore, the 7R allele has been associated
with lower self-reported rates of altruism toward both
kin and non-kin65. Thus, it comes as little surprise that
the 7R allele has been associated with elevated rates of
childhood dysphoria, and ADD among women with
SAD16. Not only may these individuals be less likely to
find normal activities rewarding, but they also may be
less likely to elicit help from parents for dealing with the
frustration that comes with a diminished sensation of re-
ward.
Decreased familial attachment and interest in kin
might act to speed up the acquisition of new knowledge
during childhood. During the juvenile period kids be-
come increasingly less dependent on their parents and
spend much more time with their peers66. In fact, atten-
tion span increases from the age of 4 to 1027. This may be
related to increased glucose utilization by the brain67.
Poorer attachment may speed the shift of attention away
from parents and towards one’s peers. In general, this
would bias the acquisition of information away from tra-
ditional sources and towards novel stimuli or people.
As adults such individuals might be expected to show
higher levels of novelty-seeking. Thus, our argument is
consistent with the hypothesis that distribution of the
7R allele worldwide reflects selection for novelty see-
king18. Novelty seeking among adults would increase the
pull factors for migration by increasing exploratory be-
havior and enhancing the attraction to more exotic ma-
tes. In support of this, recent finding suggest that those
with 7R alleles also have more multi-racial ancestries
than those without 7Rs68. Weaker parental attachment, a
history of dysphoria and less interest in promoting the
welfare of kin might also increase the push factors for
migration.
Our argument can also incorporate the suggestion
that selection for the 7R allele reflects the impact of so-
cial non-compliance on male-male reproductive strate-
gies 21. For males, reduction in prefrontal control of the
dopaminergic reward system may increase the salience
of both sex and novelty as rewards, while at the same
time decreasing the propensity for kin altruism. Such in-
dividuals may be pre-disposed to put their energy into
seeking additional sexual partners and away from invest-
ment in current kin, including offspring. Recent findings
suggest that variation of the DRD4 gene is associated
with sexual desire, function and arousal69.
Our argument may also help to elaborate the sugges-
tion that increased binge eating and reduced activity lev-
els associated with the 7R allele were selected to promote
seasonal accumulation of energy and optimal reproduc-
tive timing in a seasonal environment16. The impact of
seasonality on binging may be specific to women with
seasonal mood changes. However, increased binge eating
when food was available in fluctuating tropical environ-
ments may have lead to increased weight gain and in-
crease the probability of conception among women with
the 7R allele.
We suggest that alterations in the function of the
prefrontal cortex, associated with the 7R allele of the
DRD4 gene may have been compensated for by an in-
creased role for striatal based reward which increased
the saliency of novelty, as well as the importance of food
and sex as rewards. Together these changes would have
lead to increased variability in cognition and behavior
and promoted reproduction. Thus, the emergence of the
7R allele of the DRD4 dopamine receptor at about 50,000
ybp may be associated with an increase in cultural inno-
vation, migration and population expansion thought to
occur about this time22–24.
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Summary
Work linking ADHD, obesity, and dopamine is still in
its infancy. However, current findings suggest that alter-
ations in the dopamine reward system may underlie
overeating in much the same way as pathological gam-
bling, addiction and ADHD. Changes in the control of
striatal dopamine activity associated with low dopamine
in the prefrontal cortex may increase the salience of nov-
elty and disinhibit appetites for food and sex. In addition,
reduced reward sensitivity may lead to a failure to quit
eating when calorically satiated. Together these factors
may increase the risk of obesity in individuals with ADD.
Thus, low dopamine appears to represent a vulnerability
to developing obesity, a factor that may have gained
prominence in our current obeseogenic environment.
From an evolutionary perspective, alterations in the
dopaminergic system thought to date to roughly 50,000
ypb may represent selection on a wide range of behavior,
including learning and sociality as well as eating and sex.
A less efficient dopamine system in the prefrontal cortex
may have lead to greater salience of novelty in learning
and social interaction. Furthermore disinhibition of food
and sex impulses may have promoted reproduction.
However, even this preliminary consideration suggests
the possibility of many subtle changes in the dopami-
nergic system in response to environmental conditions.
More careful work is needed to distinguish the outcome
of dopaminergic alterations in the prefrontal cortex and
striatum and their relationship with specific dopami-
nergic genes. Such studies would benefit from the use of
endophenotypes (underlying behavioral traits) to eluci-
date the actual webs of causation70,71. Perhaps impulsivity,
behavioral inhibition, low motivation, and/or dopamine
metabolism patterns will prove to be valuable endophe-
notypes for understanding obesity and psychopathology.
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PRETILOST, POREME]AJ PA@NJE-HIPERAKTIVNOSTI I DOPAMINERGI^NI OSJE]AJ UGODE
S A @ E T A K
Epidemija pretilosti donosi zdravstvene probleme koji nisu vezani samo uz kardiovaskularne i {e}erne bolesti. Za
procjenu potencijalnih posljedica pretilosti na poreme}aj pa`nje i hiperaktivnosti (ADHD), pretra`ili smo literaturu.
Trenutna spoznaja o povezanosti pretilosti i poreme}aja pa`nje-hiperaktivnosti (ADHD) sa dopaminskim sistemom
ukazuje na povezanost dopaminskih gena, te`ine i prehrane. Detaljna promi{ljanja sugeriraju da se dopamin mijenja u
prefrontalnom korteksu kod individua sa poreme}ajem pa`nje (ADD) te da mo`e pove}ati rizik za pretilost. Zbog toga,
pojedinci i populacije sa visokom prevalencijom hiperdopaminskih gena mogu imati ve}e izglede za pojavu pretilosti.
Gledaju}i iz perspektive evolucije, promjene u dopaminskom sistemu utje~u na razli~ita pona{anja. Zaklju~ak je da
promjene u receptorima dopaminskih gena mogu biti povezani sa problemima pove}ane konzumacije hrane.
B.C. Campbell and D. Eisenberg: ADHD, Dopamin Genes and Obesity, Coll. Antropol. 31 (2007) 1: 33–38
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